eduKate Learning Manual · Molecular Biology × Protein Chemistry × Human Genetics · Secondary → JC · Separate → Compare → Correlate → Infer Molecular Disease
Wait, What? A Disease Could Be Seen as a Difference in How a Protein Moves Through an Electric Field
In 1949 Linus Pauling, Harvey Itano, S. J. Singer and Ibert Wells reported that haemoglobin from people with sickle cell anaemia behaved differently from normal haemoglobin in electrophoresis.
The disease was not being diagnosed merely by looking at red blood cells. A physical property of the haemoglobin molecule itself had changed.
People with sickle cell trait showed both normal and sickle-type haemoglobin components, linking the molecular difference to inheritance.
This was one of the landmark demonstrations that a human disease could be understood as a molecular disease.
isolate haemoglobin → apply electric field → proteins separate by electrophoretic mobility → normal and sickle samples migrate differently → trait samples show both components → molecular phenotype tracks genetic state.
The Big Question
How can a difference in protein charge and migration reveal that an inherited disease begins at the molecular level?
Quick Answer
Electrophoresis separates charged molecules in an electric field. A protein’s mobility depends on factors including net charge, size, shape and the buffer conditions.
Pauling’s team found that haemoglobin from sickle cell anaemia had a different electrophoretic mobility from normal haemoglobin. Samples from people with sickle cell trait showed both forms.
The simplest inference was that sickle cell disease involved a structurally different haemoglobin molecule encoded by an inherited genetic difference.
Later, Vernon Ingram showed that the key molecular difference involved substitution of valine for glutamic acid at position 6 of the β-globin chain. That later sequence-level result should not be retroactively attributed to the 1949 electrophoresis paper.
What You Will Learn
- how electrophoresis separates proteins
- why haemoglobin charge affects mobility
- what normal, disease and trait patterns reveal
- why trait samples were especially important
- how a protein-level phenotype can connect genetics to disease
- why the 1949 experiment did not yet reveal the exact amino-acid substitution
- how polymerisation of deoxygenated HbS produces sickling
- why heterozygosity creates mixed haemoglobin populations
- how this work helped launch molecular medicine
Part 1 — Sickle Cell Disease Had a Visible Cellular Phenotype
Under low-oxygen conditions, red blood cells containing substantial sickle haemoglobin can become distorted into elongated or sickled shapes.
That cell shape is important clinically, but it leaves a deeper question:
what molecular change makes one red cell sickle while another remains flexible?
Haemoglobin was an obvious candidate because it dominates the red blood cell and changes oxygen-binding state.
Part 2 — Electrophoresis Converts Molecular Charge Into Motion
In an electric field, a charged molecule experiences an electrical force.
A simplified relation is:
v = μE
where v is migration velocity, E is electric-field strength and μ is electrophoretic mobility.
Mobility depends on charge and frictional properties. If two haemoglobin molecules differ in net charge under the same buffer conditions, they can migrate at different rates.
Part 3 — Normal and Sickle Haemoglobins Separate
Pauling and colleagues compared haemoglobin samples from individuals with normal blood, sickle cell anaemia and sickle cell trait.
The normal and sickle-disease haemoglobins showed different electrophoretic behaviour.
This meant the disease-associated haemoglobin was not merely the same molecule sitting in a different cell environment. The protein itself carried a different physical property.
Part 4 — Why the Trait Pattern Was So Powerful
People with sickle cell trait are heterozygous: they carry one normal β-globin allele and one sickle allele.
Their haemoglobin samples contained both electrophoretic components.
This created a strong genotype–molecule bridge:
normal genotype → normal haemoglobin pattern; disease genotype → sickle pattern; heterozygous trait → both molecular forms.
The mixed pattern is difficult to explain with a purely environmental model of the disease.
Part 5 — Molecular Disease
The phrase molecular disease captured a new explanatory level.
The chain became:
heritable variation → altered protein molecule → altered molecular interactions → altered cell behaviour → clinical disease.
This architecture now feels routine in molecular medicine, but in 1949 it was conceptually transformative.
Part 6 — What the 1949 Experiment Did Not Yet Know
The electrophoretic difference showed that HbS differed physically from normal adult haemoglobin.
It did not identify the precise sequence change.
That later job was performed by Vernon Ingram, who used peptide analysis to show that sickle β-globin contains valine where normal β-globin contains glutamic acid at the sixth amino-acid position.
Modern notation often describes the variant as:
β6 Glu → Val
The historical evidence layers should remain separate.
A Charge Window
Glutamic acid has a negatively charged side chain at physiological pH, while valine is nonpolar and uncharged.
Replacing glutamate with valine therefore changes the protein’s net electrostatic properties, helping explain why HbS and HbA have different electrophoretic mobility.
The substitution also creates a hydrophobic surface patch that becomes crucial to HbS polymerisation in the deoxygenated state.
Part 7 — Why Deoxygenated HbS Polymerises
The Glu→Val substitution does more than change electrophoretic charge.
In deoxygenated HbS, the valine-containing hydrophobic site can fit into a complementary hydrophobic pocket on another haemoglobin molecule.
Repeated intermolecular association creates long fibres.
Those fibres distort the red cell, reduce deformability and contribute to vaso-occlusion and haemolysis.
sequence change → surface chemistry change → deoxy-HbS polymerisation → cell mechanics change → disease phenotype.
Part 8 — Oxygen State Matters
HbS polymerisation is strongly favoured in the deoxygenated state.
This explains why low oxygen, dehydration, acidosis and other physiological stresses can promote sickling in susceptible cells.
The gene does not act alone. Molecular phenotype depends on genotype × protein state × cellular environment.
The Historical Carrier — Pauling, Itano, Singer and Wells, 1949
The landmark paper was titled Sickle Cell Anemia, a Molecular Disease.
Its importance came from connecting an inherited disorder to a demonstrable molecular difference in a specific protein.
The work also depended on the contributions of all four named authors, especially Harvey Itano’s experimental work on haemoglobin differences.
Part 9 — Inheritance and Codominant Molecular Expression
At the molecular level, heterozygotes produce both HbA and HbS.
This is a useful reminder that dominance at the organismal phenotype level does not mean one allele is molecularly silent.
Both alleles can be expressed, producing different protein products in the same individual.
Part 10 — From Molecular Disease to Molecular Medicine
The sickle-cell work established a general strategy:
compare molecules from affected and unaffected people → find reproducible molecular difference → connect it to inheritance → connect molecular behaviour to cell pathology.
Modern medicine extends this with sequencing, proteomics, structural biology and targeted therapy.
RFE Stress Test — Molecular Variant or Sample Artefact?
- same-buffer control: are samples compared under identical pH and ionic conditions?
- repeat extraction: does the mobility difference reproduce across preparations?
- trait pattern: do heterozygotes show both molecular forms as genetics predicts?
- independent sequence test: does later peptide/DNA analysis identify a consistent variant?
- functional test: does deoxygenated HbS show abnormal polymerisation compared with HbA?
- clinical correlation: do molecular proportions and physiological conditions relate to sickling risk?
The molecular-disease model becomes strong because inheritance, protein mobility, sequence and biophysical behaviour all align.
Observation vs Inference
Observation: normal and sickle haemoglobins differ in electrophoretic mobility; trait samples contain both components.
Molecular inference: sickle cell disease is associated with a structurally different haemoglobin molecule.
Later sequence inference: the critical β-globin change is Glu6Val.
Common Misconceptions and How to Repair Them
- “Pauling discovered the exact mutation in 1949.” Repair: electrophoresis showed a molecular difference; Ingram later identified the amino-acid substitution.
- “Different electrophoretic mobility proves only size difference.” Repair: mobility reflects charge and frictional properties; HbA/HbS differ strongly in charge under the test conditions.
- “Trait means half the red cells contain HbA and half contain HbS.” Repair: individual heterozygous cells generally contain a mixture of haemoglobin types.
- “Sickling occurs because the protein is simply misshapen all the time.” Repair: deoxygenation promotes intermolecular HbS polymerisation.
- “Dominant/recessive means one allele is not expressed.” Repair: molecular products from both alleles can be present in heterozygotes.
Checkpoint Questions
- What physical property does electrophoresis exploit?
- What did the normal-vs-sickle mobility difference imply?
- Why were trait samples important?
- What did the 1949 experiment not yet identify?
- What later substitution did Ingram find?
- Why does deoxygenation promote sickling?
- What does “molecular disease” mean?
Apply It — One Band vs Two
If a haemoglobin electrophoresis sample shows both a normal-position band and an HbS-position band, the simplest interpretation is coexistence of both haemoglobin types. Genetic context is then needed to distinguish trait from other mixed-haemoglobin states.
Unfamiliar Transfer — From Genotype to Mechanism
The reusable medical reasoning chain is:
variant → altered molecular property → altered interaction → altered cell behaviour → tissue/organ consequence → clinical phenotype.
Many inherited metabolic, structural and signalling disorders can be analysed through this architecture.
Answer Key
1. Movement of charged molecules in an electric field. 2. The disease haemoglobin is physically/molecularly different. 3. They showed both normal and sickle haemoglobin forms in heterozygotes. 4. The exact amino-acid sequence change. 5. β-globin Glu6Val. 6. Deoxygenated HbS molecules polymerise through altered hydrophobic interactions. 7. A disease mechanism traceable to a specific molecular abnormality.
Can You Explain WHY?
Explain why the heterozygous trait pattern was stronger evidence than comparing only one normal and one sickle sample. A strong answer should connect inheritance → two alleles → two haemoglobin forms → two electrophoretic components → genotype–molecule correspondence.
Singapore Secondary and JC Science Bridge
Secondary Biology introduces inheritance, proteins and red blood cells. JC Biology adds protein structure and molecular genetics. This experiment links the levels directly: an inherited allele produces a measurable protein difference that changes cell mechanics and disease risk.
Deep Science Windows
- Protein electrophoresis: charge-dependent mobility remains a diagnostic principle.
- Peptide fingerprinting: Ingram used peptide analysis to localise the amino-acid difference.
- Protein polymerisation: HbS fibre nucleation and growth are kinetic processes.
- Foetal haemoglobin: HbF can reduce HbS polymerisation and disease severity.
- Genome editing: modern therapies can modify haematopoietic cells to alter globin expression or correct disease pathways.
Evidence Boundaries
The 1949 electrophoresis study established a molecular difference in haemoglobin associated with sickle cell disease and trait. It did not identify the exact amino-acid substitution; that came later through Ingram’s peptide work. Modern clinical severity also depends on HbF, co-inherited variants, physiology and treatment, not genotype alone.
Manual Summary — KNOW → CONNECT → EXPLAIN → APPLY → CHECK
- KNOW: HbA and HbS have different electrophoretic mobilities.
- CONNECT: trait samples contain both forms, linking protein pattern to inheritance.
- EXPLAIN: a molecular haemoglobin difference underlies cell sickling.
- APPLY: interpret mixed electrophoretic patterns cautiously.
- CHECK: buffer conditions, inheritance, later sequence evidence and physiological modifiers.
Teaching Guide for Parents, Tutors and Teachers
Why this opening works: a disease becomes visible as a moving protein band, connecting abstract genetics to a physical molecular measurement.
- Central reasoning model: inherited variant → protein mobility → molecular difference → cell mechanism.
- Teaching sequence: sickled cell → haemoglobin candidate → electrophoresis → normal/disease/trait comparison → molecular-disease concept → Ingram boundary → polymerisation.
- Diagnostic question: “Why does a trait sample with both bands support inheritance rather than a random laboratory artefact?”
- If stuck: treat electrophoresis as a molecular race where charge changes position.
- Ready for more: introduce peptide mapping, haemoglobin structure, polymerisation kinetics and gene therapy.
Quiet Teaching Standard: do not collapse Pauling and Ingram into one discovery. Require students to separate protein-level abnormality from later sequence-level identification.